Creating a needle-free patch to deliver diabetes medication.
Development of a Needle Free Microarray Patch for Delivery of a GLP-1 Receptor Agonist
This study is testing a new, easy-to-use patch that delivers a diabetes medication without needles, making it less scary for people with Type 2 diabetes to stick to their treatment.
Quick facts
| Grant type | Sbir 1 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vaxess Technologies, INC. NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11068410 on NIH RePORTER |
What this research studies
This research focuses on developing a needle-free microarray patch that can deliver a medication called GLP-1 receptor agonist, which is used to treat Type 2 diabetes. The approach aims to simplify the delivery method, making it easier and less intimidating for patients who may fear needles. By using a novel platform, the patch is designed to provide a consistent release of the medication, potentially improving adherence to treatment. This innovative method addresses common barriers to diabetes management, such as treatment complexity and needle anxiety.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are living with Type 2 diabetes.
Not a fit: Patients who do not have Type 2 diabetes or those who are not comfortable with new delivery methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more convenient and less intimidating way for patients to manage their Type 2 diabetes.
How similar studies have performed: Other research has shown promise in developing alternative delivery methods for diabetes medications, indicating that this approach could be viable.
Where this research is happening
Cambridge, United States
- Vaxess Technologies, INC. — Cambridge, United States (Active)
Researchers
- Principal investigator: Tussey, Lynda — Vaxess Technologies, INC.
- Study coordinator: Tussey, Lynda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.